Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Gemma Medcalf

The great schism

Technological advances in our industry are about to exacerbate societal inequality

Celgene building

Celgene gains French reimbursement for Revlimid in multiple myeloma

HAS decides it offers ' significant improvement' over existing treatments

- PMLiVE

Novartis files CAR-T therapy CTL109 in Europe

Analysts predict Kymriah could become a $1bn-plus product in Europe

- PMLiVE

Vertex’s tezacaftor/ivacaftor shows lung function boost

The combination therapy is currently under review in Europe and the US

Sobi appoints Torbjorn Hallberg as general counsel

He joins the rare diseases healthcare group from Takeda

Ashfield bolsters leadership team with two new hires

Beverley Gall and Tony Woods join as performance directors

- PMLiVE

GSK’s R&D head Vallance departs, possibly for government role

An independent panel of scientists proposed the UK role to Vallance, according to the FT

(Left to right) Brian Parsons, Jon Hallows, Gordon Muir-Jones, Kevin Ryder

Porterhouse Medical announces expansion into the US

  6 November 2017; Reading, UK – UK-based Porterhouse Medical Ltd is delighted to announce the opening of a subsidiary in Philadelphia, PA, USA. The new entity, Porterhouse Medical US, is...

Porterhouse Medical Group

Pharma’s digital patient engagement innovators identified

Novartis, Pfizer and Sanofi named best-in-class by Decision Resources Group

- PMLiVE

Exploring serious market access roadblocks for rare bleeding disorders

Ensuring that sufferers get the treatment they require

- PMLiVE

Boehringer bolsters NASH pipeline with $201m Dicerna deal

Will investigate a “new therapeutic approach” to target liver functionality

Roche Basel Switzerland

Smartphone monitoring shows its worth in Roche MS trial

The tool uses smartphone sensors to measure neurological tests

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links